Skip to content

Clinical trials

Completed Phase 2 Asperger Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asperger Syndrome Phase: Phase 2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20062
20071
20111
20123

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Forest Laboratories2
Indiana University2
University of North Carolina, Chapel Hill2
Boston University1
Cambridge Health Alliance1
National Institute of Mental Health (NIMH)1
Seaside Therapeutics, Inc.1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asperger Syndrome11
Autistic Disorder10
Autism Spectrum Disorder6
Child Development Disorders, Pervasive5
Anxiety Disorders1
Bipolar Disorder1
Developmental Disabilities1
Mental Disorders1
Mood Disorders1
Obsessive-Compulsive Disorder1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.